Derijks, Luc J. J.
Wong, Dennis R.
Hommes, Daniel W.
van Bodegraven, Adriaan A.
Article History
First Online: 6 March 2018
Compliance with Ethical Standards
:
: No funding was received for preparation of this manuscript.
: Luc Derijks and Dennis Wong have no conflicts of interest to declare. Daniel Hommes received research support, consultancy fees, and educational support from Ferring, Otsuka, Leo Pharma, Novimmune, Roche, Centocor, Schering Plough, Johnson & Johnson, PDL BioPharma, ELAN, Proctor-Gamble, Chemocentryx, AbbVie, UCB, Cellerix, AstraZeneca, Giuliani Pharma, Genentech, BMS, Philips, MSD, Serono, Falk, Genova, Takeda and Gilead. Adriaan van Bodegraven received speaker’s fees, and travel and educational support from AbbVie, Ferring, Janssen, Pfizer, MSD, Takeda, and TEVA. A Consultancy fees were provided by MSD, Pfizer, TEVA and Tramedico, and research grants were provided by ZonMW.